Calidi Biotherapeutics to participate in H.C. Wainwright 28th conference
Calidi Biotherapeutics Inc. (NYSE American: CLDI) said it will participate in the H.C. Wainwright 28th Annual Global Investment Conference.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.